Association for Multiple Endocrine Neoplasia Disorders

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7

Empowering patients through education, support and friendship

We are here to break the isolation so often felt by those with these rare diseases, and we would be delighted to welcome you into our 'family'.

The aim of our website is to direct you as quickly as possible to our support services and to information you can trust on multiple endocrine neoplasia (MEN) types 1, 2, and 3, medullary thyroid cancer (MTC), familial medullary thyroid cancer (FMTC), adrenal gland tumours (phaeochromocytomas), parathyroid hyperplasia, paragangliomas, familial isolated pituitary adenoma (FIPA) and succinate dehydrogenase (SDH) disorders.

get in touch

Contact us today if you would like to join AMEND, get support or have a question to ask.

Send Email

Facebook Group

Join our private group here where fellow patients and professionals share their experiences and support.

Visit group

Make a donation

AMEND is a entirely funded by donations so your contribution is extremely welcome.

Donate today

Latest news stories:

Professor Ashley Grossman gave a fascinating talk about neuroendocrine tumours, including those in MEN1 and other genetic syndromes at a NET Patient Day talk in late 2011.

Levothyroxine 100mcg tablets made by Teva have been withdrawn from sale in the UK by the MHRA due to concerns about interchangeability of the product with other makes of the drug.